Abstract
We report a case of gastric cancer with ascites treated with chemotherapy. The patient is a 67-year-old male. Combination chemotherapy of S-1 and CDDP was given as the first-line treatment. However, the symptoms did not improve with that regimen, so we decided to change the chemotherapy to paclitaxel as second-line treatment. After 4 cycles, CT scan revealed decreasing ascites and endoscopy a reduction of the primary tumor. The patient has maintained a condition of decreasing ascites with improvement of QOL for 8 months. This regimen is considered effective treatment for unresectable gastric cancer.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Aged
-
Antineoplastic Agents, Phytogenic / administration & dosage*
-
Cisplatin
-
Drug Administration Schedule
-
Drug Combinations
-
Drug Resistance, Neoplasm
-
Humans
-
Infusions, Intravenous
-
Male
-
Oxonic Acid
-
Paclitaxel / administration & dosage*
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / secondary
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Tegafur
Substances
-
Antineoplastic Agents, Phytogenic
-
Drug Combinations
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid
-
Paclitaxel
-
Cisplatin